KOSDAQ · Healthcare · ₩1T
₩24,400+4.27%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 6.1% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“본업 이익은 좋아졌지만 전체 수익은 더 살펴볼 때예요.”
In the company's words · 2026 2분기 filing